In this conversation with pharma change maker Paulo Moreira, we'll discuss how clinical trials and drug development can become more patient friendly. Paulo is EMD Serono's Vice President and Head of Global Clinical Operations for External Innovation. He's addressing what the industry has done wrong, why a paradigm change is needed for the clinical enterprise and how external innovation and technology must be leveraged to successfully engaging patients in the future.